WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

ATHE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$9.5M
Current Profit Margin
0%

ATHE Return on Equity

Current Company
-47.4%
Current Industry
1.3%
Current Market
-0.3%
ATHE's Return on Equity (-47.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATHE announces earnings.

ATHE Return on Assets

Current Company
-40.2%
Current Industry
-1.5%
ATHE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATHE Return on Capital Employed

Current Company
-59.74%
Current Industry
11.8%
ATHE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATHE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATHE$0.00-$8.90M-$8.97MN/AN/A
MAIA$0.00-$17.65M-$17.66MN/AN/A
AGE$94.00k-$8.01M-$14.05M-42.84%N/A
PHGE$0.00-$22.07M-$26.56MN/AN/A
OGEN$37.65k-$10.08M-$10.15M-82.77%N/A
View Top Biotech Stocks

Alterity Therapeutics Earnings & Revenue FAQ

What were ATHE's earnings last quarter?

Alterity Therapeutics (NASDAQ: ATHE) reported Q2 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Alterity Therapeutics earnings for the quarter were N/A. In the same quarter last year, Alterity Therapeutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What was ATHE's earnings growth in the past year?

As of Q4 2023, Alterity Therapeutics's earnings has grown year over year. Alterity Therapeutics's earnings in the past year totalled -$8.97 million.

What was ATHE's revenue last quarter?

Alterity Therapeutics (NASDAQ: ATHE) reported Q2 2023 revenue of N/A up N/A year over year. In the same quarter last year, Alterity Therapeutics's revenue was N/A.

What was ATHE's revenue growth in the past year?

As of Q4 2023, Alterity Therapeutics's revenue has grown null year over year. Alterity Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.